Health Care·Pharmaceuticals·$2.2B
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.25 | N/A | -10.71% |
| Revenue | N/A | N/A | N/A |
management commentary, guidance changes, and full analysis available with Pro.
| EPS | $0.25 | N/A | -10.71% |
| Revenue | N/A | N/A | N/A |
Tone: Defensive
Management expressed concerns about market conditions affecting performance. They are focused on navigating these challenges effectively.
Management highlighted challenges in the current market environment.
They emphasized the need for strategic adjustments moving forward.
The earnings report indicates that Phibro Animal Health faced challenges, leading to a slight miss on EPS. The stock reacted negatively, dropping 4.68%. Investors may be concerned about the company's ability to adapt to current market conditions, as no guidance was offered for future performance.
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
SIMON PPTY GROUP INC REIT
Nov 1, 2021